Investing in antibiotics to alleviate future catastrophic outcomes: what is the value of having an effective antibiotic to mitigate pandemic influenza?

Itamar Megiddo, Dusan Drabik, Tim Bedford, Alexander David Morton, Justus Wesseler, Ramanan Laxminarayan

Research output: Contribution to journal › Article › peer-review

14 Citations (Scopus)

33 Downloads (Pure)

4 Invited talk
1 Oral presentation

4 results
- Title
- Start date(ascending)

Filter

Economic modelling of a new payment model for antibiotics
Megiddo, I. (Speaker)
Dec 2021
Activity: Talk or presentation types › Invited talk
Models for valuing novel antibiotics and the UK “Netflix” model for purchasing antibiotics
Megiddo, I. (Speaker)
Feb 2020
Activity: Talk or presentation types › Invited talk
What is the value of a novel antibiotic? Models of withholding use.
Megiddo, I. (Speaker)
18 Jun 2019
Activity: Talk or presentation types › Invited talk
Economic Considerations for Implementation of Antibiotic Pull Incentives
Megiddo, I. (Speaker)
May 2019
Activity: Talk or presentation types › Invited talk